Efficacy and safety of nanoparticle mediated placental gene therapy in nonhuman primates
Efficacy and safety of nanoparticle mediated placental gene therapy in nonhuman primates
批准号:
10752759
负责人:
HELEN N JONES
金额:
$67.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-07 至 2028-04-30
关键词:
AddressAdmission activityAdultAdverse effectsAnimal ModelAnimalsAromataseArteriesBasic ScienceBiologyBlood VesselsCardiovascular DiseasesCathetersChemistryChildClinical ResearchDevelopmentDiabetes MellitusDiseaseDisease modelEnvironmentFetal GrowthFetal Growth RetardationFetal healthFetusFloridaFunctional disorderGeneticGiant CellsGoalsHealthHeartHumanInjectionsInsulin-Like Growth Factor IIntervention StudiesKnowledgeLeadLifeLongevityMacaca mulattaMaternal HealthMaternal PhysiologyMaternal complicationMaternal-Fetal ExchangeMediatingMetabolicMetabolismMethodsModelingMolecularMorbidity - disease rateMothersObesityOperative Surgical ProceduresOrganOutcomePathologyPeptidesPeripheralPersonal SatisfactionPhysiologicalPhysiologyPlacentaPlacental BiologyPlacental InsufficiencyPlacentationPlasmidsPolymersPositioning AttributePre-EclampsiaPregnancyPregnancy ComplicationsPregnancy OutcomePregnant WomenPremature BirthPreventionProteinsPublic HealthRegulationReporterResearchResearch PersonnelRestRiskRisk FactorsSafetySystemTestingTherapeuticTherapeutic InterventionTherapeutic StudiesTranslatingTranslational ResearchTreatment EfficacyUniversitiesUterusWisconsinWomen&aposs HealthWorkadverse pregnancy outcomeexperiencefetalgene therapyguinea pig modelimprovedin uteroin vivoinnovationinterestmodel developmentmortalitymouse modelmultidisciplinarynanocarriernanoparticlenonhuman primatenovelnovel strategiesnovel therapeutic interventionnovel therapeuticsoffspringorgan growthpediatric pharmacologypeptidomimeticspost pregnancypostnatalpregnantprematureprenatal stresspromotersafety and feasibilitytherapeutic proteintooltransgene expressiontreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Improved methods for assessing pregnancy well-being, and assessing possible molecular and genetic
correlates of poor pregnancy outcomes are currently in development. This knowledge is of limited value,
however, without the ability to intervene in troubled pregnancies. The obvious difficult step is to translate
knowledge to be gained into placental therapeutics to improve fetal health. Treating the placenta within the
pregnant mother has several significant concerns. Placental therapeutics will need to selectively target the
placenta to avoid unwanted off-target effects on maternal physiology and to ensure that treating the placenta
does not result in inadvertent negative consequences for the fetus. The long-term goal is to establish safe,
efficacious and placenta-specific gene therapy in a nonhuman primate in order to establish potential treatment
strategies for fetal growth restriction and other pregnancy pathologies in which the placenta plays a role.
Furthermore, the development of an organ-specific targeting approach in a nonhuman primate will allow the
development of other disease-specific models of pregnancy in an animal model highly translatable to human.
The overall objective of this application is to assess the feasibility and safety of a polymer-based nanoparticle
that can be taken up by the placental syncytium and result in transgene expression and allow tracking and
targeting developments for organ-specific delivery of nanocarriers. The rationale behind this proposal is that it
is expected to make significant steps toward a specific, translatable delivery mechanism for therapy in the
placenta and to broaden the capabilities of disease modelling in the nonhuman primate.
These forward-looking and innovative studies will position University of Florida and University of Wisconsin-
Madison investigators to be poised to work towards the ultimate goal, to be able to “treat the placenta”, an
ephemeral organ fundamental to our existence, yet exceedingly difficult to address with therapeutic
intervention, in the interest of improving pregnancy outcomes, women’s health and lifelong health. This study
will also open possibilities for other organ-specific disease models to be developed in the nonhuman primate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Federation of Placenta Associations
-
批准号:10321240
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
International Federation of Placenta Associations
-
批准号:10220198
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
International Federation of Placenta Associations
-
批准号:10089460
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
International Federation of Placenta Associations
-
批准号:10543984
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
Placental-specific therapy for fetal growth restriction
-
批准号:9518997
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2017
-
负责人:HELEN N JONES
-
依托单位:
Placental-specific therapy for fetal growth restriction
-
批准号:10237421
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2017
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8820274
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2014
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:9040002
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2014
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8786913
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2014
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8301347
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2012
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8451409
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2012
-
负责人:HELEN N JONES
-
依托单位: